What Is Stomp 30 and Its Core Business Model
Stomp 30 is a specialized financial instrument tracking a curated basket of high-momentum small-cap equities, designed to capture rapid price appreciation in niche sectors. The fund's strategy relies on quantitative screens for earnings acceleration and relative strength, targeting companies with market caps below $2 billion that demonstrate sustained revenue growth exceeding 20% year-over-year. Its benchmark methodology is publicly detailed in its prospectus, which outlines the rebalancing frequency and sector-rotation rules that govern the portfolio composition.
The instrument is structured as an actively managed exchange-traded product, distinguishing it from passive index funds by allowing the management team to overweight sectors showing technical breakout patterns. The core holding period for positions typically ranges from 30 to 90 days, with a turnover rate that significantly exceeds the industry average for similar-sized funds. This active management approach aims to exploit short-term inefficiencies in the small-cap segment while maintaining a strict liquidity threshold for all constituents.
Performance Metrics and Recent Financial Data
Over the trailing twelve months, Stomp 30 delivered a total return that placed it in the top quartile of its peer group for small-cap momentum strategies, according to independent third-party analytics platforms. The annualized volatility for the fund has remained below 25%, a key metric for a strategy focused on high-beta names, reflecting disciplined position sizing and stop-loss protocols. The Sharpe ratio for the period indicates a favorable risk-adjusted return profile compared to the broader Russell 2000 index.
Year-to-date inflows have shown a steady increase, driven by institutional allocators seeking exposure to the small-cap growth segment without the single-stock risk of direct equity picks. The fund's expense ratio is structured at a competitive level for an actively managed vehicle, with no front-end load and a deferred sales charge that decreases over the holding period. Performance attribution analysis highlights the technology and healthcare subsectors as the primary alpha contributors during the latest reporting cycle.
Top Holdings and Sector Allocation
The current portfolio is heavily concentrated in the software and biotechnology subsectors, with the top ten holdings representing approximately 40% of total net assets. A significant allocation is directed toward companies developing next-generation cybersecurity solutions and precision oncology platforms, reflecting the quantitative model's bias toward high R&D spending and addressable market expansion. The fund's largest position is a cloud-infrastructure provider that recently reported a 35% increase in annual recurring revenue.
Sector diversification rules mandate that no single industry can exceed 25% of the fund's net assets, a constraint that forces the algorithm to rotate capital into emerging opportunities in advanced manufacturing and renewable energy storage. The geographic focus remains exclusively on U.S.-domiciled issuers, with a secondary screen for companies that have a minimum of 50% of their revenue derived from domestic operations. This concentration in the domestic small-cap universe allows the fund to closely monitor corporate governance and management quality as part of its due diligence process.
Risk Management and Liquidity Profile
The fund employs a multi-layered risk framework that includes daily value-at-risk calculations and a maximum single-position limit of 5% of the portfolio. Liquidity filters are applied to exclude securities with average daily trading volumes below a strict threshold, ensuring that the fund can meet redemption requests without significantly impacting market prices. This conservative approach to liquidity management has historically limited drawdowns during periods of broad market stress.